CRD3874-SI for AML
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML).
Who Is on the Research Team?
Eytan Stein, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for people diagnosed with acute myeloid leukemia (AML) who are looking for new treatment options. Specific eligibility details aren't provided, but generally participants must have AML and meet certain health requirements.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- CRD3874-SI
Trial Overview
The study is testing a new drug called CRD3874-SI to see if it is safe for treating people with AML. All participants will receive this medication as part of the research.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.